Company · CIK 0001422142 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Whitehawk Therapeutics, Inc. · WHWK
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 14, 2026 AForm 4 → | Jul 30, 4:04 pm EDT | Anupam DalalDirector | 1,275,510 | $3.92 | $4,999,999 | 4,685,912 | — | late |
| Jan 8, 2019 PForm 4 → | Jan 10, 9:00 pm EST | Muneer A SatterDirector, 10% Owner | 63,818 | $2.35 | $150,290 | 5,621,835 | +1.15% | plan? |
| Jan 3, 2019 PForm 4 → | Jan 7, 9:00 pm EST | Muneer A SatterDirector, 10% Owner | 60,000 | $2.12 | $127,462 | 5,558,017 | +1.09% | plan? |
| Dec 28, 2018 PForm 4 → | Jan 2, 2019, 9:01 pm EST | Muneer A SatterDirector, 10% Owner | 60,000 | $1.80 | $108,110 | 5,498,017 | +1.10% | plan? |
| Dec 21, 2018 PForm 4 → | Dec 27, 7:13 pm EST | Muneer A SatterDirector, 10% Owner | 60,000 | $1.74 | $104,134 | 5,438,017 | +1.12% | plan? late |
| Dec 18, 2018 PForm 4 → | Dec 20, 7:04 pm EST | Muneer A SatterDirector, 10% Owner | 60,000 | $1.92 | $115,224 | 5,378,017 | +1.13% | plan? |
| Dec 12, 2018 GForm 5 → | Feb 13, 2019, 4:41 pm EST | Joseph H. GardnerPresident, Director | 300,000 | — | — | 150,000 | — | plan? |
| Dec 12, 2018 PForm 4 → | Dec 14, 8:55 pm EST | Muneer A SatterDirector, 10% Owner | 60,000 | $2.02 | $121,340 | 5,318,017 | +1.14% | plan? |
| Dec 7, 2018 PForm 4 → | Dec 11, 8:52 pm EST | Muneer A SatterDirector, 10% Owner | 60,000 | $2.12 | $127,242 | 5,258,017 | +1.15% | plan? |
| Dec 3, 2018 PForm 4 → | Dec 6, 8:54 pm EST | Muneer A SatterDirector, 10% Owner | 60,000 | $2.09 | $125,352 | 5,198,017 | +1.17% | plan? |
| Nov 28, 2018 PForm 4 → | Nov 30, 9:00 pm EST | Muneer A SatterDirector, 10% Owner | 60,000 | $1.98 | $118,524 | 5,138,017 | +1.18% | plan? |
| Nov 9, 2018 PForm 4 → | Nov 14, 4:25 pm EST | Stephen J HoffmanChief Executive Officer, Director | 31,967 | $2.01 | $64,136 | 31,967 | — | plan? late |
| Sep 24, 2018 DJForm 4 → | Sep 26, 9:40 pm EDT | Caley CasteleinDirector | 1,872,513 | — | — | 0 | — | plan? |
| Aug 20, 2018 SForm 4 → | Aug 22, 4:07 pm EDT | Novartis Bioventures Ltd +110% Owner | 5,300 | $3.90 | $20,670 | 5,800,250 | −0.09% | plan? |
| Jun 28, 2018 PForm 4 → | Jul 2, 4:56 pm EDT | ORBIMED ADVISORS LLC +1Director, 10% Owner | 777,500 | $3.85 | $2,993,375 | 5,193,946 | +17.6% | plan? |
| Jun 28, 2018 PForm 4 → | Jul 2, 4:51 pm EDT | Chau Quang KhuongDirector, 10% Owner | 777,500 | $3.85 | $2,993,375 | 5,193,946 | +17.6% | plan? |
| Jun 28, 2018 PForm 4 → | Jun 29, 4:17 pm EDT | Muneer A SatterDirector, 10% Owner | 1,818,182 | $3.85 | $7,000,001 | 5,078,017 | +55.8% | plan? |
| Mar 21, 2018 PForm 4 → | Mar 23, 6:23 pm EDT | Muneer A SatterDirector, 10% Owner | 5,000 | $4.88 | $24,390 | 3,259,835 | +0.15% | plan? |
| Mar 19, 2018 PForm 4 → | Mar 21, 4:52 pm EDT | Muneer A SatterDirector, 10% Owner | 13,000 | $4.97 | $64,585 | 3,254,835 | +0.40% | plan? |
| Dec 22, 2017 JForm 5 → | Feb 14, 2018, 5:54 pm EST | Caley CasteleinDirector | 18,802 | — | — | 10,920 | — | plan? |
| Dec 22, 2017 JForm 5 → | Feb 14, 2018, 5:50 pm EST | Anupam DalalDirector | 10,151 | — | — | 2,269 | — | plan? |
| Mar 15, 2017 PForm 4 → | Mar 17, 8:42 pm EDT | Caley CasteleinDirector | 400,000 | $5.00 | $2,000,000 | 1,611,408 | +33.0% | plan? |
| Mar 15, 2017 PForm 4 → | Mar 17, 8:42 pm EDT | Chau Quang KhuongDirector, 10% Owner | 762,995 | $5.00 | $3,814,975 | 4,416,446 | +20.9% | plan? |
| Mar 15, 2017 PForm 4 → | Mar 17, 8:41 pm EDT | Kevin G. PetersChief Scientific Officer | 3,642 | $5.00 | $18,210 | 320,536 | +1.15% | plan? |
| Mar 15, 2017 PForm 4 → | Mar 17, 8:40 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 762,995 | $5.00 | $3,814,975 | 4,416,446 | +20.9% | plan? |
| Mar 15, 2017 PForm 4 → | Mar 17, 8:39 pm EDT | Joseph H. GardnerSee Remarks, Director | 99,996 | $5.00 | $499,980 | 593,019 | +20.3% | plan? |
| Mar 15, 2017 PForm 4 → | Mar 17, 8:37 pm EDT | Paul M WeissDirector | 272,302 | $5.00 | $1,361,510 | 1,576,167 | +20.9% | plan? |
| Mar 15, 2017 PForm 4 → | Mar 17, 8:36 pm EDT | Novartis Bioventures Ltd +110% Owner | 560,000 | $5.00 | $2,800,000 | 5,805,550 | +10.7% | plan? |
| Mar 15, 2017 PForm 4 → | Mar 17, 7:34 pm EDT | Muneer A SatterDirector, 10% Owner | 1,120,000 | $5.00 | $5,600,000 | 3,241,835 | +52.8% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 AForm 4/A → | Sep 18, 4:45 pm EDT | Scott M. GiacobelloCHIEF FINANCIAL OFFICER | 236,952 | — | — | 118,476 | — | |
| Sep 15, 2026 AForm 4/A → | Sep 18, 4:44 pm EDT | Bryan BallSee remarks | 183,266 | — | — | 91,633 | — | |
| Sep 15, 2026 AForm 4/A → | Sep 18, 4:43 pm EDT | David DornanChief Scientific Officer | 171,774 | — | — | 85,887 | — | |
| Sep 15, 2026 AForm 4/A → | Sep 18, 4:41 pm EDT | David James LennonCHIEF EXECUTIVE OFFICER, Director | 387,914 | — | — | 193,957 | — | |
| Sep 15, 2026 AForm 4/A → | Sep 18, 4:40 pm EDT | Margaret DuganChief Medical Officer | 162,500 | — | — | 81,250 | — | |
| Sep 15, 2026 AForm 4 → | Sep 15, 7:07 pm EDT | David James LennonCHIEF EXECUTIVE OFFICER, Director | 387,914 | — | — | 193,957 | — | amended |
| Sep 15, 2026 AForm 4 → | Sep 15, 7:07 pm EDT | Scott M. GiacobelloCHIEF FINANCIAL OFFICER | 236,952 | — | — | 118,476 | — | amended |
| Sep 15, 2026 AForm 4 → | Sep 15, 7:06 pm EDT | Margaret DuganChief Medical Officer | 162,500 | — | — | 81,250 | — | amended |
| Sep 15, 2026 AForm 4 → | Sep 15, 7:05 pm EDT | David DornanChief Scientific Officer | 171,774 | — | — | 85,887 | — | amended |
| Sep 15, 2026 AForm 4 → | Sep 15, 7:05 pm EDT | Bryan BallSee remarks | 183,266 | — | — | 91,633 | — | amended |
| Sep 9, 2026 AForm 4 → | Sep 11, 4:04 pm EDT | Vijay K IyengarDirector | 76,080 | — | — | 76,080 | — | |
| Jun 12, 2026 AForm 4 → | Jul 30, 4:04 pm EDT | Anupam DalalDirector | 38,040 | — | — | 38,040 | — | late |
| Jun 12, 2026 AForm 4 → | Jun 15, 5:27 pm EDT | Baiteng ZhaoDirector | 38,040 | — | — | 38,040 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 5:26 pm EDT | Emma ReeveDirector | 38,040 | — | — | 38,040 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 5:24 pm EDT | Richard E MarounDirector | 38,040 | — | — | 38,040 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 5:23 pm EDT | Mohammad HirmandDirector | 38,040 | — | — | 38,040 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 5:22 pm EDT | Neil DesaiDirector | 38,040 | — | — | 38,040 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 5:21 pm EDT | Caley CasteleinDirector | 38,040 | — | — | 38,040 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 5:18 pm EDT | Behzad Aghazadeh +2Director, 10% Owner | 38,040 | — | — | 38,040 | — | |
| Feb 15, 2019 AForm 4 → | Feb 20, 4:54 pm EST | Steve PakolaChief Medical Officer | 125,000 | — | — | 125,000 | — | |
| Feb 15, 2019 AForm 4 → | Feb 20, 4:53 pm EST | Joseph H. GardnerPresident, Director | 150,000 | — | — | 150,000 | — | |
| Feb 15, 2019 AForm 4 → | Feb 20, 4:52 pm EST | Stephen J HoffmanChief Executive Officer, Director | 365,000 | — | — | 365,000 | — | |
| Feb 15, 2019 AForm 4 → | Feb 20, 4:52 pm EST | Kevin G. PetersChief Scientific Officer | 125,000 | — | — | 125,000 | — | |
| Feb 15, 2019 AForm 4 → | Feb 20, 4:51 pm EST | Michael W RogersChief Financial Officer | 215,328 | — | — | 215,328 | — | |
| Oct 26, 2018 AForm 4 → | Nov 16, 4:21 pm EST | Pravin DugelDirector | 2,500 | — | — | 2,500 | — | late |
| Jun 20, 2018 AForm 4 → | Jun 22, 6:14 pm EDT | Muneer A SatterDirector, 10% Owner | 21,400 | — | — | 21,400 | — | |
| Jun 20, 2018 AForm 4 → | Jun 22, 6:13 pm EDT | Anupam DalalDirector | 21,400 | — | — | 21,400 | — | |
| Jun 20, 2018 AForm 4 → | Jun 22, 6:08 pm EDT | Chau Quang KhuongDirector | 21,400 | — | — | 21,400 | — | |
| Jun 20, 2018 AForm 4 → | Jun 22, 6:07 pm EDT | Pravin DugelDirector | 21,400 | — | — | 21,400 | — | |
| Jun 20, 2018 AForm 4 → | Jun 22, 6:04 pm EDT | Steven PrelackDirector | 21,400 | — | — | 21,400 | — | |
| Jun 20, 2018 AForm 4 → | Jun 22, 6:01 pm EDT | Caley CasteleinDirector | 21,400 | — | — | 21,400 | — | |
| Jun 20, 2018 AForm 4 → | Jun 22, 5:54 pm EDT | Cheryl CohenDirector | 42,800 | — | — | 42,800 | — | |
| Apr 23, 2018 AForm 4 → | Apr 25, 8:28 pm EDT | Stephen J HoffmanChief Executive Officer, Director | 300,000 | — | — | 300,000 | — | |
| Apr 23, 2018 AForm 4 → | Apr 25, 8:26 pm EDT | Kevin G. PetersChief Scientific Officer | 100,000 | — | — | 100,000 | — | |
| Apr 23, 2018 AForm 4 → | Apr 25, 8:24 pm EDT | Michael W RogersChief Financial Officer | 144,000 | — | — | 144,000 | — | |
| Apr 23, 2018 AForm 4 → | Apr 25, 8:23 pm EDT | Steve PakolaChief Medical Officer | 100,000 | — | — | 100,000 | — | |
| Apr 23, 2018 AForm 4 → | Apr 25, 8:22 pm EDT | Joseph H. GardnerPresident, Director | 150,000 | — | — | 150,000 | — | |
| Dec 14, 2017 AForm 4 → | Dec 18, 5:13 pm EST | Stephen J HoffmanChief Executive Officer, Director | 586,012 | $5.50 | $3,223,066 | 0 | — | |
| Dec 14, 2017 AForm 4 → | Dec 18, 5:09 pm EST | Joseph H. GardnerPresident, Director | 135,000 | $5.50 | $742,500 | 0 | — | |
| Dec 14, 2017 AForm 4 → | Dec 18, 5:06 pm EST | Michael W RogersChief Financial Officer | 293,006 | $5.50 | $1,611,533 | 0 | — |